Click here for downloadable file for journalists. Consilient Health welcomes the decision by the National Institute for Health and Care […]
All the latest news and events
Newsletter signup
Keep up to date with news about Consilient Health and the healthcare sector.
Signup
Upcoming Events
Consilient Health will be attending the following conferences:
JP Morgan Healthcare Conference
13-16 January 2020
San Fransisco, California
Bio-Europe Spring
23-25 March 2020
Paris, France
Please contact us if you are interested in meeting.
Code No: CORP-CH-236
Date of Preparation: November 2019
News
Click here for downloadable file for journalists. Consilient Health welcomes the decision by the Scottish Medicines Consortium (SMC) to recommend […]
Click here for downloadable file for journalists. Consilient Health welcomes the draft final appraisal document published today by the National […]
Consilient Health are proud to announce the grant of marketing authorisation for Bencium® in Finland, in August 2019 following approvals […]
Consilient Health is extremely disappointed that the initial recommendation from the National Institute for Health and Care Excellence (NICE), detailed […]
Consilient Health is pleased to announce that we have signed a long term, exclusive agreement with Angelini Farmaceutica S.A for […]
2019 has brought a new product to Consilient Health. Bentexo is the latest addition to the bone health portfolio, a […]
Consilient Health are pleased to announce the signing of a long-term, exclusive distribution agreement with bene-Arzneimittel GmbH, a Munich-based pharmaceutical […]
Consilient Health is pleased to announce the appointment of Harald F. Stock PhD as Non-Executive Director of the Company. Harald […]
Consilient Health is pleased to announce the appointment of Mr John Dixon as Non-Executive Director of the Company. John joined […]